Evidence map›Paper›PMID 37873422›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Parallel detection of multi-contrast MRI and Deuterium Metabolic Imaging (DMI) for time-efficient characterization of neurological diseases.

Yanning Liu, Henk M De Feyter, Zachary A Corbin, Robert K Fulbright, Scott McIntyre, Terence W Nixon, Robin A de Graaf

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yanning LiuDepartment of Biomedical Engineering, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Henk M De FeyterDepartment of Radiology and Biomedical Imaging, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Zachary A CorbinDepartment of Neurology, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Robert K FulbrightDepartment of Radiology and Biomedical Imaging, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Scott McIntyreDepartment of Radiology and Biomedical Imaging, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Terence W NixonDepartment of Radiology and Biomedical Imaging, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Robin A de GraafDepartment of Biomedical Engineering, Magnetic Resonance Research Center (MRRC), Yale University, New Haven, CT, United States.
Yale University · US

Funding

Deuterium metabolic imaging (DMI) of neurological diseaseR01EB025840 · NIBIB · YALE UNIVERSITY · PI ROBIN A DE GRAAF, Henk De Feyter · 2019 to 2026
$4.2M
Validation of imaging brain tumor metabolism using deuterated glucoseR01EB033764 · NIBIB · YALE UNIVERSITY · PI ROBIN A DE GRAAF, Henk De Feyter · 2023 to 2026
$2.4M
NIBIB NIH HHS R01 EB025840NIBIB NIH HHS R01 EB033764
6 · The paper itself

Abstract

Deuterium Metabolic Imaging (DMI) is a novel method that can complement traditional anatomical magnetic resonance imaging (MRI) of the brain. DMI relies on the MR detection of metabolites that become labeled with deuterium (

Identifiers

PMID37873422
PMCPMC10593017
OpenAlexW4387338413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.